These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 15094177)

  • 1. Treatment of extensive small cell lung cancer.
    Davies AM; Lara PN; Lau DH; Gandara DR
    Hematol Oncol Clin North Am; 2004 Apr; 18(2):373-85. PubMed ID: 15094177
    [No Abstract]   [Full Text] [Related]  

  • 2. Treatment of recurrent small cell lung cancer.
    Davies AM; Evans WK; Mackay JA; Shepherd FA
    Hematol Oncol Clin North Am; 2004 Apr; 18(2):387-416. PubMed ID: 15094178
    [No Abstract]   [Full Text] [Related]  

  • 3. Lung cancer. Chemotherapy.
    Engelking C
    Am J Nurs; 1987 Nov; 87(11):1438-9, 1440-1. PubMed ID: 2823610
    [No Abstract]   [Full Text] [Related]  

  • 4. Etoposide (VP-16) containing combination chemotherapy for treatment of patients with small cell lung cancer.
    Behera D; Jindal SK; Sharma SC
    Indian J Chest Dis Allied Sci; 1995; 37(1):15-9. PubMed ID: 16892733
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Polychemotherapy of small-cell lung cancer].
    Krawczyk K; Krochmal M; Pawlicki M; Kulpa J
    Pneumonol Pol; 1983 Feb; 51(2):101-5. PubMed ID: 6308583
    [No Abstract]   [Full Text] [Related]  

  • 6. [Meta-analysis of the value of cisplatin in primary therapy of small-cell bronchial carcinoma].
    Rosien B
    Strahlenther Onkol; 2001 Feb; 177(2):114-6. PubMed ID: 11233835
    [No Abstract]   [Full Text] [Related]  

  • 7. [Chemotherapy in cancer of the lung].
    Gütz S
    MMW Fortschr Med; 2006 Jun; 148(22):33-4. PubMed ID: 16821578
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A phase I trial defining the maximum tolerated systemic exposure of topotecan in combination with Carboplatin and Etoposide in extensive stage small cell lung cancer.
    Gillenwater HH; McCune JS; Lindley C; Faucette S; Shord S; Donahue A; Socinski MA; Stewart CF; Zamboni WC; Kirstein MN; Moore D
    Cancer Invest; 2005; 23(6):511-9. PubMed ID: 16203659
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thalidomide in small-cell lung cancer: is it a tombstone?
    Rossi A; Gridelli C; Bria E
    J Clin Oncol; 2008 Jan; 26(1):160; author reply 160. PubMed ID: 18165652
    [No Abstract]   [Full Text] [Related]  

  • 10. Radiochemotherapy in small-cell lung cancer.
    Kepka L; Sprawka A; Casas F; Abdel-Wahab S; Agarwal JP; Jeremic B
    Expert Rev Anticancer Ther; 2009 Oct; 9(10):1379-87. PubMed ID: 19827997
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radiochemotherapy in the elderly with lung cancer.
    Casas F; Kepka L; Agarwal JP; Dawotola D; Gaye P; Abdel-Wahab S; Vashkevitch L; Saghatelyan T; Perin B; Jeremic B
    Expert Rev Anticancer Ther; 2009 Oct; 9(10):1405-11. PubMed ID: 19827999
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemotherapy plus surgery versus surgery alone in non-small-cell lung cancer.
    Chanarin N
    N Engl J Med; 1994 Jun; 330(24):1756; author reply 1757. PubMed ID: 8190142
    [No Abstract]   [Full Text] [Related]  

  • 13. Topotecan for the treatment of small-cell lung cancer.
    Nicum SJ; O'Brien ME
    Expert Rev Anticancer Ther; 2007 Jun; 7(6):795-801. PubMed ID: 17555389
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemotherapy for lung cancer: the state of the art in 2009.
    Higgins MJ; Ettinger DS
    Expert Rev Anticancer Ther; 2009 Oct; 9(10):1365-78. PubMed ID: 19827996
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phase II trial of amrubicin for treatment of refractory or relapsed small-cell lung cancer: Thoracic Oncology Research Group Study 0301.
    Onoda S; Masuda N; Seto T; Eguchi K; Takiguchi Y; Isobe H; Okamoto H; Ogura T; Yokoyama A; Seki N; Asaka-Amano Y; Harada M; Tagawa A; Kunikane H; Yokoba M; Uematsu K; Kuriyama T; Kuroiwa Y; Watanabe K;
    J Clin Oncol; 2006 Dec; 24(34):5448-53. PubMed ID: 17135647
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reponses to topoisomerase-I inhibitors in extensive small-cell lung cancer: chance or chromosomes?
    Perry MC
    J Clin Oncol; 2006 May; 24(13):1980-1. PubMed ID: 16648497
    [No Abstract]   [Full Text] [Related]  

  • 17. Evaluation of curative and palliative radiotherapy efficacy in extensive stage small cell lung cancer.
    Diniz G; Unlu I; Gokce T; Kilciksiz S; Gayaf M; Komurcuoglu B; Karadogan I; Aktas S; Akcay C
    Saudi Med J; 2006 Jul; 27(7):992-6. PubMed ID: 16830017
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The debate about maintenance is not over in small-cell lung cancer.
    Artac M; Bozcuk H
    J Clin Oncol; 2007 Dec; 25(36):5840; author reply 5840-1. PubMed ID: 18089887
    [No Abstract]   [Full Text] [Related]  

  • 19. Could we expect to improve survival in small cell lung cancer?
    El Maalouf G; Rodier JM; Faivre S; Raymond E
    Lung Cancer; 2007 Aug; 57 Suppl 2():S30-4. PubMed ID: 17686444
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Comprehensive evaluation of treatment outcome of various therapies in 508 cases of small cell lung cancer].
    Zhang Y; Gu YF; Deng LH; Yang SS; Li SY
    Zhonghua Yi Xue Za Zhi; 2004 Jun; 84(11):917-9. PubMed ID: 15329278
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.